Viarisio, D., Müller-Decker, K., Hassel, J. C., Flechtenmacher, C., Pawlita, M., & Gissmann, L. (2017). The BRAF inhibitor vemurafenib enhances UV-induced skin carcinogenesis in Beta HPV38 E6 and E7 transgenic mice. The journal of investigative dermatology, 137(1), . https://doi.org/10.1016/j.jid.2016.08.030
Chicago-Zitierstil (17. Ausg.)Viarisio, Daniele, Karin Müller-Decker, Jessica C. Hassel, Christa Flechtenmacher, Michael Pawlita, und Lutz Gissmann. "The BRAF Inhibitor Vemurafenib Enhances UV-induced Skin Carcinogenesis in Beta HPV38 E6 and E7 Transgenic Mice." The Journal of Investigative Dermatology 137, no. 1 (2017). https://doi.org/10.1016/j.jid.2016.08.030.
MLA-Zitierstil (9. Ausg.)Viarisio, Daniele, et al. "The BRAF Inhibitor Vemurafenib Enhances UV-induced Skin Carcinogenesis in Beta HPV38 E6 and E7 Transgenic Mice." The Journal of Investigative Dermatology, vol. 137, no. 1, 2017, https://doi.org/10.1016/j.jid.2016.08.030.